10Elms LLP’s CVS Health CVS Stock Holding History

10Elms LLP’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-28	Closed	-$1.95K	–	500
2025 Q2	$1.95K	Sell	28 -35	-56%	-$2.29K	﹤0.01%	494
2025 Q1	$4.24K	Sell	63 -137	-69%	-$8.2K	﹤0.01%	511
2024 Q4	$8.98K	Buy	+200	New	+$11.2K	0.01%	453

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

10Elms LLP's CVS Position: Q3 2025 in Review

10Elms LLP sold out of CVS Health (CVS) in Q3 2025, closing a stake of 28 shares — an estimated $1.95K sold.

10Elms LLP first reported a position in CVS in Q4 2024 and held it in 3 quarters. The position peaked at $8.98K in Q4 2024. 1,837 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

10Elms LLP reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
10Elms LLP sold 28 CVS Health shares in Q3 2025, an estimated $1.95K.
10Elms LLP first reported a position in CVS Health in Q4 2024 and held it in 3 quarters.
10Elms LLP's CVS Health position peaked at $8.98K in Q4 2024.
1,837 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on 10Elms LLP's 13F filing for Q3 2025, filed 12 Nov 2025.